These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 32792853)

  • 1. Insights into Nanomedicine for Immunotherapeutics in Squamous Cell Carcinoma of the head and neck.
    Xu Q; Fang M; Zhu J; Dong H; Cao J; Yan L; Leonard F; Oppel F; Sudhoff H; Kaufmann AM; Albers AE; Qian X
    Int J Biol Sci; 2020; 16(14):2506-2517. PubMed ID: 32792853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy for Head and Neck Squamous Cell Carcinoma: A Review of Current and Emerging Therapeutic Options.
    Moskovitz JM; Moy J; Seiwert TY; Ferris RL
    Oncologist; 2017 Jun; 22(6):680-693. PubMed ID: 28507203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The promise of immunotherapy in head and neck squamous cell carcinoma.
    Economopoulou P; Agelaki S; Perisanidis C; Giotakis EI; Psyrri A
    Ann Oncol; 2016 Sep; 27(9):1675-85. PubMed ID: 27380958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoantigens in immunotherapy and personalized vaccines: Implications for head and neck squamous cell carcinoma.
    Zolkind P; Dunn GP; Lin T; Griffith M; Griffith OL; Uppaluri R
    Oral Oncol; 2017 Aug; 71():169-176. PubMed ID: 27751760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor Immunology and Immunotherapy for Head and Neck Squamous Cell Carcinoma.
    Moskovitz JM; Ferris RL
    J Dent Res; 2018 Jun; 97(6):622-626. PubMed ID: 29489423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in Immunotherapy of Head and Neck Squamous Cell Carcinoma.
    Almokadem S
    Curr Mol Pharmacol; 2016; 9(3):226-230. PubMed ID: 26177644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunotherapy: a new alternative treatment for head and neck squamous cell carcinoma].
    Bron L; Romero P
    Bull Cancer; 2007 Sep; 94(9):793-7. PubMed ID: 17878099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy for Head and Neck Squamous Cell Carcinoma.
    Schoppy DW; Sunwoo JB
    Hematol Oncol Clin North Am; 2015 Dec; 29(6):1033-43. PubMed ID: 26568546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA-based immunotherapy for HPV-associated head and neck cancer.
    Aggarwal C
    Immunotherapy; 2016 Oct; 8(10):1187-92. PubMed ID: 27605067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunotherapeutic studies of head and neck tumors : Highlights of the 2016 ASCO Annual Meeting].
    Busch CJ; Laban S; Knecht R; Hoffmann TK
    HNO; 2016 Oct; 64(10):708-16. PubMed ID: 27604282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immuno-oncology in head and neck squamous cell cancers: News from clinical trials, emerging predictive factors and unmet needs.
    Cavalieri S; Rivoltini L; Bergamini C; Locati LD; Licitra L; Bossi P
    Cancer Treat Rev; 2018 Apr; 65():78-86. PubMed ID: 29574334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Treatment Options in Head and Neck Cancer.
    Schuler PJ; Laban S; Doescher J; Bullinger L; Hoffmann TK
    Oncol Res Treat; 2017; 40(6):342-346. PubMed ID: 28521322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing an Immunotherapy Strategy for the Effective Treatment of Oral, Head and Neck Squamous Cell Carcinoma.
    Bell RB; Leidner R; Feng Z; Crittenden MR; Gough MJ; Fox BA
    J Oral Maxillofac Surg; 2015 Dec; 73(12 Suppl):S107-15. PubMed ID: 26608138
    [No Abstract]   [Full Text] [Related]  

  • 14. Checkpoint immunotherapy in head and neck cancers.
    Zolkind P; Uppaluri R
    Cancer Metastasis Rev; 2017 Sep; 36(3):475-489. PubMed ID: 28836124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy in head and neck cancers: A new challenge for immunologists, pathologists and clinicians.
    Outh-Gauer S; Alt M; Le Tourneau C; Augustin J; Broudin C; Gasne C; Denize T; Mirghani H; Fabre E; Ménard M; Scotte F; Tartour E; Badoual C
    Cancer Treat Rev; 2018 Apr; 65():54-64. PubMed ID: 29547766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head and Neck Cancer Immunotherapy beyond the Checkpoint Blockade.
    Heath BR; Michmerhuizen NL; Donnelly CR; Sansanaphongpricha K; Sun D; Brenner JC; Lei YL
    J Dent Res; 2019 Sep; 98(10):1073-1080. PubMed ID: 31340724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy in head and neck cancer: current practice and future possibilities.
    Agada FO; Alhamarneh O; Stafford ND; Greenman J
    J Laryngol Otol; 2009 Jan; 123(1):19-28. PubMed ID: 18761763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel treatments for head and neck squamous cell carcinoma: preclinical identification and clinical investigation.
    Bowles DW; McDermott JD; Jimeno A
    Future Oncol; 2014 May; 10(6):1065-80. PubMed ID: 24941990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy for head and neck squamous cell carcinoma.
    Li Q; Prince ME; Moyer JS
    Oral Oncol; 2015 Apr; 51(4):299-304. PubMed ID: 25624094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy of head and neck cancer.
    Resser JR; Carbone DP
    Curr Opin Oncol; 1998 May; 10(3):226-32. PubMed ID: 9619359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.